Pancreatic Cancer Research

ResearcherLevine Cancer InstituteActive in the last 2 years

Kunal C. Kadakia

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3574-4141; OpenAlex author ID A5074396684. Sources: ClinicalTrials.gov.

Their work

Papers
3 (first author 1, last author 1)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2021: 1 paper · 2022: 1 trial · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 3

  1. Comparison of Early-, Average-, and Late-Onset Pancreatic Cancer in a Multi-Site Cancer Center: Treatment Patterns and Outcomes. Last author DOI 10.17294/2330-0698.2191↗
  2. Neoadjuvant treatment in resectable pancreatic cancer: Why is upfront surgery so hard to be beaten? First author DOI 10.5306/wjco.v16.i9.108955↗
  3. Early-onset pancreatic cancer: an institutional series evaluating end-of-life care. Co-author DOI 10.1007/s00520-020-05876-1↗

Trials 1

  1. Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc Adenocarcinoma Principal investigator NCT05376592↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mohamed E. Salem · 2 shared papers, 2021–2026 · strength 0.55
  2. Chirag K. Patel · 1 shared paper, 2026 · strength 0.43
  3. Raphael L. C. Araújo · 1 shared paper, 2025 · strength 0.42
  4. Pedro Luiz Serrano Usón · 1 shared paper, 2025 · strength 0.42
  5. Declan Walsh · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.